Kimberly A. Hepner

Kimberly A. Hepner

Auto-generated profile, based on publicly available information

Kimberly A. Hepner

RAND Corporation

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2007 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
KHKimberly A. Hepner
Kimberly A. Hepner
MRMelissa Rowe
Melissa Rowe
KRKathryn Rost
Kathryn Rost
SHScot C. Hickey
Scot C. Hickey
CSCathy D. Sherbourne
Cathy D. Sherbourne
LRLisa V. Rubenstein
Lisa V. Rubenstein
Few studies have assessed clinician adherence to depression practice guidelines and the relationship between clinician adherence and depression outcomes. To estimate how frequently specific guideline recommendations are followed and to assess whether following guideline recommendations is linked to improved depression outcomes. Observational analysis of data collected from 1996 to 1998 in 3 randomized clinical trials. 45 primary care practices in 13 U.S. states. 1131 primary care patients with depression. Expert panel methods were used to develop a patient survey-based index that measured adherence to clinical practice guidelines on depression. Rates of adherence to the 20 indicators that form the index were evaluated. Multivariable regression that controlled for case mix was used to assess how index scores predicted continuous and dichotomous depression measures at 12, 18, and 24 months. Quality of care was high (clinician adherence > or =79%) for 6 indicators, including primary care clinician detection of depression. Quality of care was low (adherence, 20% to 38%) for 8 indicators, including management of suicide risk (3 indicators), alcohol abuse (2 indicators), and elderly patients; assessment of symptoms and history of depression; and treatment adjustment for patients who did not respond to initial treatment. Greater adherence to practice guidelines significantly predicted fewer depressive symptoms on continuous measures (P < 0.001 for 12 months, P < 0.01 for 18 months, and P < 0.001 for 24 months) and dichotomous measures (P < 0.05 for 18 and 24 months). Data are based on patient self-report. Possible changes in practice since 1998 may limit the generalizability of the findings. Adherence to guidelines was high for one third of the recommendations that were measured but was very low for nearly half of the measures, pointing to specific needs for quality improvement. Guideline-concordant depression care appears to be linked to improved outcomes in primary care patients with depression.

15 November 2005 in Health Services Research
Verified
Journal Article
Closed access
PDF file
NCNicholas G. Castle
Nicholas G. Castle
Julie BrownJulie Brown
Julie Brown
KHKimberly A. Hepner
Kimberly A. Hepner
RHRon D. Hays
Ron D. Hays

15 November 2005 in Health Services Research
Verified
Journal Article
Closed access
PDF file
AOA. James O'MAlley
A. James O'MAlley
AZAlan M. Zaslavsky
Alan M. Zaslavsky
RHRon D. Hays
Ron D. Hays
KHKimberly A. Hepner
Kimberly A. Hepner
SKSan Keller
San Keller
PCPaul D. Cleary
Paul D. Cleary

1 June 2016 in Health Affairs
Verified
Journal Article
Closed access
PDF file
HPHarold Alan Pincus
Harold Alan Pincus
SSSarah Hudson Scholle
Sarah Hudson Scholle
BSBrigitta Spaeth-Rublee
Brigitta Spaeth-Rublee
KHKimberly A. Hepner
Kimberly A. Hepner
JBJonathan Brown
Jonathan Brown
Following up on its Crossing the Quality Chasm report, in 2006 the Institute of Medicine issued a report that included sweeping recommendations to improve the quality of behavioral health care in the United States. To date, few of those recommendations have been implemented, and there is little evidence that behavioral health care quality has improved significantly over the past ten years. However, the advent of health care reform, parity of insurance coverage, and growing recognition of the impact of behavioral health disorders on population health and health care costs have created new demands and opportunities for expanded and innovative strategies to assess the quality of care for this patient population. We provide an overview of the current state of quality measurement in behavioral health, identify key priorities for measure development, and describe the most important challenges. We recommend a coordinated plan that would boost investment in developing, evaluating, and implementing behavioral health quality measures; conduct research to develop the evidence necessary to support a more robust set of measures; overcome barriers to the improvement and linking of data sources; and expand efforts to build the capacity of the clinical workforce, in partnership with consumers, to improve quality.

6 June 2011 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
KWKatherine E. Watkins
Katherine E. Watkins
SHSarah B. Hunter
Sarah B. Hunter
KHKimberly A. Hepner
Kimberly A. Hepner
SPSusan M. Paddock
Susan M. Paddock
ECErin de la Cruz
Erin de la Cruz
JGJim Gilmore
Jim Gilmore
Depression and substance abuse are the second and fourth most common mental disorders1,2 and are the leading causes of disability, reduced quality of life, and adverse social consequences.3 Although depression and substance abuse frequently occur together, individuals with both disorders rarely receive treatment for both.4 The consequences of this unmet need are great. Individuals with co-occurring depression and substance abuse overuse high-cost, crisis-oriented services, and the interactive nature of the 2 disorders leads to poorer depression and substance abuse treatment outcomes compared with the outcomes when only 1 disorder is treated.5,6

15 November 2005 in Health Services Research
Verified
Journal Article
Closed access
PDF file
SKSan Keller
San Keller
AOA. James O'Malley
A. James O'Malley
RHRon D. Hays
Ron D. Hays
RMRebecca A. Matthew
Rebecca A. Matthew
AZAlan M. Zaslavsky
Alan M. Zaslavsky
PCPaul D. Cleary
Paul D. Cleary